Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2021 | CML: care versus cure

Francois-Xavier Mahon • 26 Nov 2021
ASH 2021
Chronic Myeloid Leukemia Leukemia

Francois-Xavier Mahon, MD, PhD, University of Bordeaux, Bordeaux, France, shares his thoughts on the likelihood of achieving cure in chronic myeloid leukemia (CML). This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

More from Francois-Xavier Mahon

Recommendations for treatment discontinuation in CML
2:18
Recommendations for treatment discontinuation in CML
Francois-Xavier Mahon • 22 Oct 2022
Design & aims of the EURO-SKI trial in CML
0:54
Design & aims of the EURO-SKI trial in CML
Francois-Xavier Mahon • 22 Oct 2022
Key challenges in CML: QoL, managing CML in resource-challenged countries & achieving a cure
1:24
Key challenges in CML: QoL, managing CML in resource-challenged countries & achieving a cure
Francois-Xavier Mahon • 22 Oct 2022
Feasibility of treatment cessation in patients with CML with atypical BCR-ABL fusion transcripts
1:05
Feasibility of treatment cessation in patients with CML with atypical BCR-ABL fusion transcripts
Francois-Xavier Mahon • 26 Nov 2021

Related Videos

Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
2:40
Frontline management of Richter’s transformation: current approaches and remaining uncertainties
Philip Thompson • 22 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals